Roche Seeks Avastin Breast Cancer Indication In Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
Marketing authorization application includes recent Phase III E2100 trial.
You may also be interested in...
Avastin sBLA Submission Means Breast Cancer Pricing Could Be Set By November
Genentech is seeking a six-month priority review for bevacizumab in breast cancer.
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Hospira’s Mayne Event: Acquisition Strengthens Oncology Portfolio
Merger will create the leading generic injectable pharmaceutical company in the world.